![](http://media.springernature.com/m312/springer-static/image/art%3A10.1038%2Fs41423-021-00709-5/MediaObjects/41423_2021_709_Fig1_HTML.png)
References
Scharping, N. E. et al. Nat. Immunol. 22, 205–215 (2021).
Ho, P. C. et al. Cell 162, 1217–1228 (2015).
Geiger, R. et al. Cell 167, 829–842 (2016).
Brand, A. et al. Cell Metab. 24, 657–671 (2016).
Qiu, J. et al. Cell Rep. 27, 2063–2074 (2019).
Ma, X. et al. Cell Metab. 30, 143–156 (2019).
Palazon, A. et al. Cancer Cell 32, 669–683 (2017).
Zhang, Y. et al. Cancer Cell 32, 377–391 (2017).
Bengsch, B. et al. Immunity 45, 358–373 (2016).
Scharping, N. E. et al. Immunity 45, 374–388 (2016).
Song, M. et al. Nature 562, 423–428 (2018).
Nabe, S. et al. Cancer Sci. 109, 3737–3750 (2018).
Wei, J. et al. Nature 576, 471–476 (2019).
Ogando, J. et al. J. Immunother. Cancer 7, 151 (2019).
Menk, A. V. et al. J. Exp. Med. 215, 1091–1100 (2018).
Acknowledgements
This work is supported by the Key Program of National Natural Science Foundation of China (81730039) and National Natural Science Foundation of China Grants (81701574).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Qian, C., Cao, X. Reversing the mitochondrial stress-induced exhaustion of CD8+ T cells for improving cancer immunotherapy. Cell Mol Immunol 18, 1634–1637 (2021). https://doi.org/10.1038/s41423-021-00709-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41423-021-00709-5
- Springer Nature Limited
This article is cited by
-
Mesothelin-based CAR-T cells exhibit potent antitumor activity against ovarian cancer
Journal of Translational Medicine (2024)
-
Ligand-based adoptive T cell targeting CA125 in ovarian cancer
Journal of Translational Medicine (2023)